Foghorn Therapeutics Inc.
← Back to FHTX Overview

Foghorn Therapeutics Inc. (FHTX)

Profitability & Net Margin History

Current Net Margin

-234.28%

Foghorn Therapeutics Inc. currently has a net profit margin of -234.28%.

Financial Fundamentals

FHTXQuarterly Data • 5Y View

Historical Margin Data

DateRev ($B)NI ($B)Net MarginChange (bps)
2025-12-310.01-0.02-234.28%3989
2025-09-300.01-0.02-194.39%4295
2025-06-300.01-0.02-237.34%7909
2025-03-310.01-0.02-316.43%36645
2024-12-310.00-0.02-682.88%43798
2024-09-300.01-0.02-244.90%8871
2024-06-300.01-0.02-333.61%16176
2024-03-310.01-0.03-495.37%7751
2023-12-310.01-0.02-417.85%33578
2023-09-300.02-0.01-82.07%44457
2023-06-300.01-0.03-526.65%4762
2023-03-310.01-0.03-574.27%11612
2022-12-310.00-0.03-690.39%30195
2022-09-300.01-0.03-388.44%21987
2022-06-300.00-0.03-608.31%7827
2022-03-310.00-0.03-686.58%340080
2021-12-310.00-0.03-4087.38%5952238
2021-09-300.00-0.03-63609.76%5532624
2021-06-300.00-0.02-8283.51%24645
2021-03-310.00-0.02-8037.06%23306
2020-12-310.00-0.02-8270.12%199077
2020-09-300.00-0.02-10260.89%
2020-06-300.00-0.02
2020-03-310.00-0.01
2019-12-310.00-0.02
2019-09-300.00-0.01
2019-06-300.00-0.01
2019-03-310.00-0.01
2018-06-300.00-0.01
2018-03-310.00-0.01

* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.